Microdosing psychedelics is the practice of taking very small subhallucinogenic doses of psychedelic substances, most commonly LSD or mushrooms containing dry psilocybin. People conducted a large observational study in which microdoser considered the benefits and challenges of microduction.
The most commonly reported benefits were improved mood, focus, and creativity, while the challenges most frequently reported were illegality, physiological discomfort, and other perceived challenges, including a microdosing risk profile that was not known due to lack of research. You can also order shrooms online.
What is microdosing?
With psychedelics, the "microdosis" is so low that the person consuming the substance does not experience a marked change in consciousness. The dose is roughly one-tenth of the total recreational dose: 5 to 20 micrograms of LSD or 0.1 to 0.3 grams of psilocybin-containing dried mushrooms.
There are almost no experimental studies that show whether microdosing has any benefit at all. This is still in its infancy and much remains to be done. This paper offers a number of potential research avenues for future empirical studies to investigate and report on a number of challenges related to microdosing which are important for protection.
Improved mood was the most commonly reported benefit at just over one quarter of reports. This includes reports of happiness and calm, reduced depressive symptoms and improved outlook, and optimism and appreciation.
Creativity was next most common, including meta-creative processes like perspective-shifting, divergent thinking, and curiosity. Indeed, our previous research found that microdosers were more wise, open-minded, and creative than non-microdosers.